• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病中的糖尿病肾病:致病机制、患者相关因素及治疗选择综述

Diabetic kidney disease in type 2 diabetes: a review of pathogenic mechanisms, patient-related factors and therapeutic options.

作者信息

Woodhams Louise, Sim Tin Fei, Chalmers Leanne, Yeap Bu, Green Daniel, Schlaich Markus, Schultz Carl, Hillis Graham

机构信息

Curtin Medical School, Curtin University of Technology, Perth, Western Australia, Australia.

Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, Western Australia, Australia.

出版信息

PeerJ. 2021 Apr 19;9:e11070. doi: 10.7717/peerj.11070. eCollection 2021.

DOI:10.7717/peerj.11070
PMID:33976959
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8061574/
Abstract

The global prevalence of diabetic kidney disease is rapidly accelerating due to an increasing number of people living with type 2 diabetes. It has become a significant global problem, increasing human and financial pressures on already overburdened healthcare systems. Interest in diabetic kidney disease has increased over the last decade and progress has been made in determining the pathogenic mechanisms and patient-related factors involved in the development and pathogenesis of this disease. A greater understanding of these factors will catalyse the development of novel treatments and influence current practice. This review summarises the latest evidence for the factors involved in the development and progression of diabetic kidney disease, which will inform better management strategies targeting such factors to improve therapeutic outcomes in patients living with diabetes.

摘要

由于2型糖尿病患者人数不断增加,全球糖尿病肾病的患病率正在迅速上升。它已成为一个重大的全球性问题,给本已不堪重负的医疗系统带来了越来越大的人力和财力压力。在过去十年中,人们对糖尿病肾病的关注度有所提高,在确定该疾病发生发展的致病机制和患者相关因素方面取得了进展。对这些因素的更深入了解将推动新型治疗方法的开发,并影响当前的临床实践。本综述总结了糖尿病肾病发生发展相关因素的最新证据,这将为针对这些因素制定更好的管理策略提供依据,以改善糖尿病患者的治疗效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00a7/8061574/6982d436009c/peerj-09-11070-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00a7/8061574/6982d436009c/peerj-09-11070-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00a7/8061574/6982d436009c/peerj-09-11070-g001.jpg

相似文献

1
Diabetic kidney disease in type 2 diabetes: a review of pathogenic mechanisms, patient-related factors and therapeutic options.2型糖尿病中的糖尿病肾病:致病机制、患者相关因素及治疗选择综述
PeerJ. 2021 Apr 19;9:e11070. doi: 10.7717/peerj.11070. eCollection 2021.
2
Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.糖尿病肾病的多学科管理:一项系统评价与荟萃分析
JBI Database System Rev Implement Rep. 2016 Jul;14(7):169-207. doi: 10.11124/JBISRIR-2016-003011.
3
Diabetic Kidney Disease in Older People with Type 2 Diabetes Mellitus: Improving Prevention and Treatment Options.老年人 2 型糖尿病中的糖尿病肾病:改善预防和治疗选择。
Drugs Aging. 2020 Aug;37(8):567-584. doi: 10.1007/s40266-020-00773-y.
4
Long noncoding RNA: an emerging player in diabetes and diabetic kidney disease.长链非编码 RNA:在糖尿病和糖尿病肾病中的新兴角色。
Clin Sci (Lond). 2019 Jun 20;133(12):1321-1339. doi: 10.1042/CS20190372. Print 2019 Jun 28.
5
Biomarkers in Diabetic Retinopathy.糖尿病视网膜病变中的生物标志物
Rev Diabet Stud. 2015 Spring-Summer;12(1-2):159-95. doi: 10.1900/RDS.2015.12.159. Epub 2015 Aug 10.
6
Comorbidity network for chronic disease: A novel approach to understand type 2 diabetes progression.慢性病共病网络:一种理解 2 型糖尿病进展的新方法。
Int J Med Inform. 2018 Jul;115:1-9. doi: 10.1016/j.ijmedinf.2018.04.001. Epub 2018 Apr 9.
7
Sex Differences in Diabetic Kidney Disease.糖尿病肾病的性别差异。
Mayo Clin Proc. 2020 Mar;95(3):587-599. doi: 10.1016/j.mayocp.2019.08.026.
8
Kidney Disease in Diabetes糖尿病肾病
9
Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".糖尿病肾病:新的临床和治疗问题。意大利糖尿病学会和意大利肾脏病学会关于“糖尿病肾病的自然病程和肾功能受损的 2 型糖尿病患者的高血糖治疗”的联合立场声明。
Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1127-1150. doi: 10.1016/j.numecd.2019.07.017. Epub 2019 Oct 2.
10
Diabetic nephropathy in insulin-dependent diabetes mellitus: pathogenesis and treatment strategies.胰岛素依赖型糖尿病中的糖尿病肾病:发病机制与治疗策略
Neth J Med. 1990 Feb;36(1-2):74-85.

引用本文的文献

1
Pharmacological Nephroprotection in Chronic Kidney Disease Patients with Type 2 Diabetes Mellitus-Clinical Practice Position Statement of the Polish Society of Nephrology.2型糖尿病慢性肾脏病患者的药物性肾保护——波兰肾脏病学会临床实践立场声明
Int J Mol Sci. 2024 Dec 2;25(23):12941. doi: 10.3390/ijms252312941.
2
Potentials of Natural Antioxidants in Reducing Inflammation and Oxidative Stress in Chronic Kidney Disease.天然抗氧化剂在减轻慢性肾脏病炎症和氧化应激方面的潜力
Antioxidants (Basel). 2024 Jun 20;13(6):751. doi: 10.3390/antiox13060751.
3
Pathomechanisms of Diabetic Kidney Disease.

本文引用的文献

1
Effects of aldose reductase inhibitors on renal blood flow parameters in patients with early diabetic nephropathy.醛糖还原酶抑制剂对早期糖尿病肾病患者肾血流参数的影响。
J Diabetes Complications. 2020 Sep;34(9):107620. doi: 10.1016/j.jdiacomp.2020.107620. Epub 2020 May 11.
2
Fructose Production and Metabolism in the Kidney.肾脏中的果糖生产与代谢。
J Am Soc Nephrol. 2020 May;31(5):898-906. doi: 10.1681/ASN.2019101015. Epub 2020 Apr 6.
3
Effects of ACE Inhibitors and Angiotensin Receptor Blockers in Normotensive Patients with Diabetic Kidney Disease.
糖尿病肾病的发病机制
J Clin Med. 2023 Nov 27;12(23):7349. doi: 10.3390/jcm12237349.
4
Risk factors of chronic kidney disease among type 2 diabetic patients with longer duration of diabetes.2 型糖尿病患者中糖尿病病程较长者发生慢性肾脏病的危险因素。
Front Endocrinol (Lausanne). 2022 Dec 9;13:1079725. doi: 10.3389/fendo.2022.1079725. eCollection 2022.
5
Ameliorative Effects of Camel Milk and Its Exosomes on Diabetic Nephropathy in Rats.骆驼奶及其外泌体对大鼠糖尿病肾病的改善作用
Membranes (Basel). 2022 Oct 28;12(11):1060. doi: 10.3390/membranes12111060.
6
Endothelin Receptor Antagonists as a Potential Treatment of Diabetic Nephropathy: A Systematic Review.内皮素受体拮抗剂作为糖尿病肾病的一种潜在治疗方法:一项系统评价
Cureus. 2021 Nov 7;13(11):e19325. doi: 10.7759/cureus.19325. eCollection 2021 Nov.
血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂在血压正常的糖尿病肾病患者中的作用。
Horm Metab Res. 2020 May;52(5):289-297. doi: 10.1055/a-1138-0959. Epub 2020 Mar 27.
4
Uraemic toxin-induced inflammation and oxidative stress in human endothelial cells: protective effect of polyphenol-rich extract from açaí.阿萨伊多酚丰富提取物对人内皮细胞尿毒症毒素诱导的炎症和氧化应激的保护作用。
Exp Physiol. 2020 Mar;105(3):542-551. doi: 10.1113/EP088080. Epub 2020 Jan 30.
5
Investigation of the Mechanism Underlying Calcium Dobesilate-Mediated Improvement of Endothelial Dysfunction and Inflammation Caused by High Glucose.钙波司他汀通过改善高糖引起的内皮功能障碍和炎症的作用机制研究。
Mediators Inflamm. 2019 Oct 21;2019:9893682. doi: 10.1155/2019/9893682. eCollection 2019.
6
Diabetic Kidney Disease: Diagnosis, Treatment, and Prevention.糖尿病肾病:诊断、治疗与预防。
Am Fam Physician. 2019 Jun 15;99(12):751-759.
7
Lipoxin A4 restores oxidative stress-induced vascular endothelial cell injury and thrombosis-related factor expression by its receptor-mediated activation of Nrf2-HO-1 axis.脂氧素 A4 通过其受体介导的 Nrf2-HO-1 轴激活来恢复氧化应激诱导的血管内皮细胞损伤和血栓形成相关因子的表达。
Cell Signal. 2019 Aug;60:146-153. doi: 10.1016/j.cellsig.2019.05.002. Epub 2019 May 3.
8
Role of protein kinase C in diabetic complications.蛋白激酶C在糖尿病并发症中的作用。
Expert Rev Endocrinol Metab. 2010 Jan;5(1):77-88. doi: 10.1586/eem.09.74.
9
AKF-PD alleviates diabetic nephropathy via blocking the RAGE/AGEs/NOX and PKC/NOX Pathways.AKF-PD 通过阻断 RAGE/AGEs/NOX 和 PKC/NOX 通路缓解糖尿病肾病。
Sci Rep. 2019 Mar 13;9(1):4407. doi: 10.1038/s41598-018-36344-w.
10
Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial.口服镁补充剂改善了糖尿病肾病患者的血脂谱,但增加了胰岛素抵抗:一项双盲随机对照临床试验。
Biol Trace Elem Res. 2020 Jan;193(1):23-35. doi: 10.1007/s12011-019-01687-6. Epub 2019 Mar 5.